Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](I-Mab Biopharma)"
Count: 24
Selected: 0
NCT03235752Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis
NCT05001347A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
NCT04869501Expanded Access Study of TJ004309 in Patients With Advanced or Metastatic Cancer
NCT06285201Study of Felzartamab in Healthy Adult Subjects
NCT05709093A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)
NCT05511350Expanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001
NCT05338580Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid Tumors
NCT05148533A Study of Single Drug TJ011133 and Toripalimab Combine Treatment for Advanced Solid Tumor
NCT05145907Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors
NCT05140824A Study to Evaluate the Safety, Tolerability, and PK Profile of Single and Multiple Doses TJ202 in Patient With Systemic Lupus Erythematosus
NCT04947033A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors
NCT04900818Study of TJ033721 in Subjects With Advanced or Metastatic Solid Tumors
NCT04678921Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors
NCT04633057A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency
NCT04600817A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)
NCT04457856A Study of TJ003234 in Rheumatoid Arthritis Patients
NCT04341116Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
NCT04322006A Phase I/II Study of TJ004309 for Advanced Solid Tumor
NCT04202003A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
NCT04001075Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TJ107 in Chinese Patients With Advanced Solid Tumors
NCT03952091TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
NCT03860038TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
NCT03794180Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Healthy Adult Subjects
NCT03934814Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma